ASEP Medical arranges $1.16-million LIFE offering

Executive Summary

• ASEP Medical Holdings Inc. announced a listed issuer financing exemption offering of up to 5,557,619 units at C$0.21 per unit, targeting gross proceeds of up to C$1,165,000.
• Each unit consists of one common share and one warrant; warrants have a 60‑day hold period and allow purchase of a share at C$0.28 for 36 months after the offering closes.
• Net proceeds are earmarked for research & development, repayment of existing debt, and general working capital; closing is expected on or about March 31 2026, subject to customary conditions and CSE approval.

Key Details

• Offering Size: Up to 5,557,619 units (each = 1 common share + 1 warrant).
• Price per Unit: C$0.21.
• Maximum Gross Proceeds: C$1,165,000.
• Warrant Terms:
• Hold period – 60 days from issuance.
• Exercise price – C$0.28 per share.
• Expiration – 36 months after the offering’s completion.
• Exemption Used: Listed Issuer Financing Exemption (LIFE) under NI 45‑106, applicable in all Canadian provinces except Quebec; no resale restrictions imposed.
• Use of Proceeds:
• Research & development activities.
• Repayment of existing indebtedness.
• General working capital and other purposes as described in the offering document.
• Closing Date: Expected on or about March 31 2026, subject to customary closing conditions including CSE approval.
• Documentation: Offering memorandum available on SEDAR+ and the company’s website; investors are urged to review it before investing.

Notable Quotes

(No direct quotes were provided in the release.)